Tariff Cuts Favor US Strengths
New Delhi's Union Budget 2026-27 has quietly introduced tariff concessions likely to provide a significant boost to U.S. exports. A new analysis by the Global Trade Research Initiative (GTRI) indicates that exemptions align directly with sectors where American companies excel, potentially improving market access across critical industries.
Aviation and Nuclear Power Gains
In civil and defense aviation, India has eliminated duties on crucial aircraft components and maintenance, repair, and overhaul (MRO) inputs. This move directly benefits U.S. aerospace manufacturers and their engine and maintenance suppliers. Similarly, the budget offers long-term certainty for U.S. nuclear equipment makers by setting zero customs duty on nuclear-generation equipment and project imports until 2035.
Clean Energy and Electronics Push
Barriers are also lowering for U.S. clean energy, critical minerals, and electronics exports. Duty-free imports of capital goods for lithium-ion cell manufacturing and specific materials like sodium antimonate for solar glass production are set to reduce costs for U.S. suppliers of advanced machinery and components.
Healthcare Sector Benefits
The healthcare sector sees zero duty applied to certain high-value cancer drugs, rare-disease medicines, and essential medical device components, including X-ray tubes and flat-panel detectors. This policy shift is expected to ease market access for U.S. pharmaceutical and medical technology exporters.
Strategic Trade Alignment
Ajay Srivastava, founder of GTRI, noted that these combined changes "quietly help U.S. in capital-intensive, technology-led exports to India." This follows similar initiatives in the 2025-26 budget, which included tariff reductions on high-value motorcycles and components for satellite ground installations, further signaling a strategic alignment to foster specific U.S. imports.
